O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Document Type
Journal Article
Publication Date
1-1-2014
Journal
Oncology
Volume
87
Issue
6
Inclusive Pages
371-380
DOI
10.1159/000366425
Keywords
Adenocarcinoma--drug therapy; Antineoplastic Combined Chemotherapy Protocols--therapeutic use; Esopheageal Neoplasms--drug therapy; Hemolytic-Uremic Syndrome--etiology; Stomach Neoplasms--drug therapy
APA Citation
Ahlgren, J., Patel, N., Simmens, S., Akin, E., Bishop, C., Kirkel, D., Siegel, P., Schuck, S., Guebre-Xabiher, H., & Siegel, R. (2014). O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.. Oncology, 87 (6). http://dx.doi.org/10.1159/000366425
Peer Reviewed
1